The glutamate transport inhibitor DL-Threo-β-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The glutamate transport inhibitor DL-Threo-β-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cells
Authors
Keywords
SLC1A1, EAAT3, SLC1A3, EAAT1, GSH, Glutathione, LoVo, HCT116, Irinotecan
Journal
BMC CANCER
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-05-16
DOI
10.1186/s12885-015-1405-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance
- (2015) Niels F. Jensen et al. Molecular Oncology
- Microarray-based detection and expression analysis of ABC and SLC transporters in drug-resistant ovarian cancer cell lines
- (2013) Radosław Januchowski et al. BIOMEDICINE & PHARMACOTHERAPY
- Glutamate acid decarboxylase 1 promotes metastasis of human oral cancer by β-catenin translocation and MMP7 activation
- (2013) Ryota Kimura et al. BMC CANCER
- Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancer
- (2013) Lucía Cortejoso et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Changes in the expression of the glutamate transporter EAAT3/EAAC1 in health and disease
- (2013) Massimiliano G. Bianchi et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
- (2013) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- The SLC1 high-affinity glutamate and neutral amino acid transporter family
- (2013) Yoshikatsu Kanai et al. MOLECULAR ASPECTS OF MEDICINE
- A colorectal cancer classification system that associates cellular phenotype and responses to therapy
- (2013) Anguraj Sadanandam et al. NATURE MEDICINE
- Mechanisms of Glutamate Transport
- (2013) Robert J. Vandenberg et al. PHYSIOLOGICAL REVIEWS
- Glutathione synthesis
- (2012) Shelly C. Lu BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Molecular Predictors of Response to Chemotherapy in Colorectal Cancer
- (2011) Rodrigo Dienstmann et al. CANCER JOURNAL
- The Na+/H+ exchanger NHE1, but not the Na+, cotransporter NBCn1, regulates motility of MCF7 breast cancer cells expressing constitutively active ErbB2
- (2011) Gitte Lauritzen et al. CANCER LETTERS
- Glutamate Transport Decreases Mitochondrial pH and Modulates Oxidative Metabolism in Astrocytes
- (2011) G. Azarias et al. JOURNAL OF NEUROSCIENCE
- Clinical, laboratory and molecular factors predicting chemotherapy efficacy and toxicity in colorectal cancer
- (2010) Wei Chua et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- In vitrodrug responses in primary and metastatic colorectal cancers
- (2010) Eugene Mechetner et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Discovery of the First Selective Inhibitor of Excitatory Amino Acid Transporter Subtype 1
- (2009) Anders A. Jensen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Elevated Glutathione Levels Confer Cellular Sensitization to Cisplatin Toxicity by Up-Regulation of Copper Transporter hCtr1
- (2008) H. H. W. Chen et al. MOLECULAR PHARMACOLOGY
- The Role of the Mammalian Copper Transporter 1 in the Cellular Accumulation of Platinum-Based Drugs
- (2008) C. A. Larson et al. MOLECULAR PHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started